GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar ...

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters) - ...

LONDON, Aug 12 (Reuters) - Shares in GSK (GSK.L), opens new tab, Sanofi (SASY.PA), opens new tab, Haleon (HLN.L), opens new tab and Pfizer (PFE.N), opens new tab began to recover on Friday after the ...

Haleon - GSK's recently spun off consumer health unit - is not a party to U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday. LONDON, Aug 11 (Reuters) - ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

"The position advocated by plaintiffs has the potential to substantially and considerably impact judicial administration and case assignments throughout the commonwealth of Pennsylvania, at all ...

GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such case that was about to go to trial in the U.S. In a brief statement, the ...

LONDON, Sept 20 (Reuters) - Haleon HLN.L on Tuesday said it had notified GSK GSK.L and Pfizer PFE.N that it had rejected their requests for indemnification in relation to U.S.-based litigation over ...

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by our window is picking up, and the ...